The SPTBN2 gene helps nerve cells, especially in the cerebellum, keep their shape and pass signals smoothly. This gene plays an important role in balance and coordination. When it does not work properly, people may develop ataxia, which means unsteady movement, along with speech or eye movement problems. Pathogenic variants in the SPTBN2 gene are linked to spinocerebellar ataxia type 5 and some early-onset cerebellar conditions. Some people also have low muscle tone, tremor, or delays in motor development.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the working parts of cells. Others mostly control when certain processes take place, where they happen, and how strongly they run. Together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
SPTBN2Gene function
What if the gene works
The SPTBN2 gene helps make beta-III spectrin, a protein that supports nerve cell shape and traffic, especially in the cerebellum. This helps brain cells work smoothly for balance and coordinated movement.
Risk
What if the gene does not work
Variants in the SPTBN2 gene mainly affect coordination and balance because the cerebellum does not work normally. Milder variants may cause slowly progressive adult-onset ataxia, while more severe variants can begin in childhood with delayed motor development and learning difficulties.
Treatment
What does that mean for your treatment
No SPTBN2-specific treatment or drug-selection approach is currently established for people with a pathogenic variant in the SPTBN2 gene. Care is usually symptom-based, and current research is focused on understanding how SPTBN2-related changes affect nerve cells rather than guiding a specific medicine choice.
Conditions associated with SPTBN2
Gene function
What if the gene works
Smooth, coordinated movement depends on nerve cells keeping their shape and sending signals in an organized way. The SPTBN2 gene helps build and arrange the support system inside these cells, especially in brain areas involved in coordination. That helps explain how the SPTBN2 gene supports balance and movement in everyday life.
The SPTBN2 gene helps build a flexible framework just beneath the cell surface. This framework helps nerve cells keep their shape and stay stable during everyday signaling.
Inside nerve cells, the SPTBN2 gene helps hold key proteins in the right spots along the cell membrane. This orderly layout supports clear communication between cells.
Its protein also supports the movement of cell cargo, such as packets of proteins, to the places where they are needed. This helps long, branching nerve cells stay organized.
In the cerebellum, a brain area that fine tunes balance and coordination, the SPTBN2 gene supports specialized nerve cells that smooth out movement. This helps everyday actions like walking, reaching, and keeping steady.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effects and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SPTBN2 gene can change the shape, stability, or binding of the beta-III spectrin protein, so nerve cells may struggle to keep key proteins in the right place. Some SPTBN2 gene variants partly reduce protein function, while more disruptive variants can leave very little working protein. This range often matches symptoms that start later and are milder, or begin earlier with more noticeable balance and coordination problems.
How variants are linked to conditions
Variants in the SPTBN2 gene are linked to inherited cerebellar ataxia caused by SPTBN2 gene changes. Pathogenic variants can cause spinocerebellar ataxia type 5, a usually dominant condition that affects balance, coordination, and walking over time. Other variants in both copies of the SPTBN2 gene can lead to SCAR14, a recessive form that often begins in childhood and may include developmental delay, low muscle tone, or eye movement differences.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most variants do not directly affect health. They simply contribute to natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences are involved. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SPTBN2, risk is mainly shaped by whether someone carries a disease-causing gene change, often inherited in a family. There is not yet broadly confirmed evidence that lifestyle or environmental factors clearly increase or reduce SPTBN2-related risk, so people with concerns about their personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SPTBN2 variants
The SPTBN2 inheritance pattern depends on the condition linked to the variant. Some SPTBN2-related conditions are inherited in an autosomal dominant way, which means one altered copy of the SPTBN2 gene from either parent can be enough for a child to inherit the condition, with a 50% chance in each pregnancy. Other SPTBN2-related conditions follow an autosomal recessive pattern, which means a child usually inherits two altered copies, one from each parent. In families, this means SPTBN2 can be passed from either mother or father, but the chance for a child depends on the specific condition and variant involved.
What does my SPTBN2 result mean for my family?
For SPTBN2, what it means for family members depends on the condition linked to the result. Some SPTBN2 changes are tied to a dominant form of balance and coordination problems, so close relatives such as parents, brothers, sisters, and children may also carry the same change. Other SPTBN2 changes cause a recessive condition, which means relatives may be healthy carriers even if they do not have symptoms.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked with ataxia or related symptoms, SPTBN2 genetic testing uses a blood or saliva sample. A lab reads the DNA in the SPTBN2 gene and checks for variants that may help explain symptoms or confirm a diagnosis. Results can show a disease-causing variant, a harmless change, or one whose meaning is still unclear.
When should I consider getting a genetic test?
Consider testing for the SPTBN2 gene if you or a close relative has ongoing balance and coordination problems, trouble walking, slurred speech, or a family history of an inherited condition affecting movement. In children, testing may also be considered with early movement problems or developmental delay. A result can help confirm the cause and clarify family risk.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and on the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as response to medications, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or be linked to more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way medications work. It focuses on gene-drug patterns to help explain why the same treatment may not have the same effect in every person. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SPTBN2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about symptoms, treatment, or side effects are best discussed with your doctor.
History
SPTBN2 entered medical genetics through studies of inherited balance and coordination problems in families with spinocerebellar ataxia. In 1996, researchers mapped spinocerebellar ataxia type 5 to chromosome 11, and later work identified variants in the SPTBN2 gene as the cause in affected families. Interest grew because one large family studied with this condition was linked to the paternal line of Abraham Lincoln, which brought unusual public attention to a rare ataxia gene. Building on this early work, scientists also found that different SPTBN2 variants can cause a childhood onset condition now known as spinocerebellar ataxia, autosomal recessive type 14. These discoveries helped show that one gene could be tied to more than one inherited neurologic condition.